ZÁPAL A JEHO OVPLYVNENIE SET

Literatúra

Hale L.P., Haynes B.F.: Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CDS, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. Journal of Immunology 149 (12): 3809-3816, 1992.
Impact factor: 6,937 Exp-35

Lindner A., Förster O.: Berichtüber den Einfluβ von Wobenzym auf verschiedene Rattenpfotenödeme. Wissenschaftliche Monographic 1985.

Bodi T.: The Effect of Oral Bromelains on Tissue Permeability to Antibiotics and Pain Response to Bradykinin: Double Studies on Human Subjects 1966. Clinical Medicine 7: (1966).

Guggenbichler J.P.: Einfluβhydrolytischer Enzyme auf Thrombusbildung und Thrombolyse. Die Medizinische Welt 39: 277, 1988.

Leskovar P.: AIDS: Neuartige Therapiekonzepte. Dtsch. Zeitschr. Onkol. 22: 26, 1990.

Desser L., Sakalová A., Závadová E., Holomanova D., Mohr T.: Concentrations of soluble tumor necrosis factor receptors, β2-microglobulin, IL-6 and TNF in serum of multiple myeloma patients after chemotherapy and after combined enzýme + chemotherapy. International Journal of Immunotherapy XIII (3/4): 121-130, 1997.
Impact factor: 0,172 Exp-22

Závadová E., Desser L, Mohr T.: Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation. Cancer Biotherapy 10 (2): 147-152, 1995.
Impact factor: 0,781 Exp-92

Kunze, R., Ransberger, K., Buschmans, E., Stauder, G., Gebauer, F.: The adhesion protein CD44 is modulated by proteolytic enzymes, 2nd Int. Congress on Biological Response Modifiers, San Diego/Ca. 1993 (presented Poster 21).

Nakazawa M., Emancipator S.N., Lamn M.E.: Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. Journal of Experimental Medicine 164: 1973-1987, 1986.
Impact factor: 14,384 Nefro-19

Steffen C., Menzel J.: Grundlagenuntersuchung zur Enzymtherapie bei Immunkomplexkrankheiten. Wiener klinische Wochenschrift 97 (8): 2-11, 1985. Imun-83


Úvod O firme Kontakty Pomáhame druhým Poradňa Stránky pre laikov wobenzym.cz
Zápal a jeho ovplyvnenie SET Zvýšenie využiteľnosti antibiotík proteolytickými enzýmami Angiológia, flebológia Gynekológia Chirurgia, traumatológia, ortopédia Imunológia Lymfológia ORL Pediatria Reumatológia Športová medicína Stomatológia Urológia Literatúra Časopisy s Impact faktorom Ostatná literatúra SPC Wobenzym SPC Phlogenzym	ZÁPAL A JEHO OVPLYVNENIE SET Literatúra Hale L.P., Haynes B.F.: Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CDS, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. Journal of Immunology 149 (12): 3809-3816, 1992. Impact factor: 6,937 Exp-35 Lindner A., Förster O.: Berichtüber den Einfluβ von Wobenzym auf verschiedene Rattenpfotenödeme. Wissenschaftliche Monographic 1985. Bodi T.: The Effect of Oral Bromelains on Tissue Permeability to Antibiotics and Pain Response to Bradykinin: Double Studies on Human Subjects 1966. Clinical Medicine 7: (1966). Guggenbichler J.P.: Einfluβhydrolytischer Enzyme auf Thrombusbildung und Thrombolyse. Die Medizinische Welt 39: 277, 1988. Leskovar P.: AIDS: Neuartige Therapiekonzepte. Dtsch. Zeitschr. Onkol. 22: 26, 1990. Desser L., Sakalová A., Závadová E., Holomanova D., Mohr T.: Concentrations of soluble tumor necrosis factor receptors, β2-microglobulin, IL-6 and TNF in serum of multiple myeloma patients after chemotherapy and after combined enzýme + chemotherapy. International Journal of Immunotherapy XIII (3/4): 121-130, 1997. Impact factor: 0,172 Exp-22 Závadová E., Desser L, Mohr T.: Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation. Cancer Biotherapy 10 (2): 147-152, 1995. Impact factor: 0,781 Exp-92 Kunze, R., Ransberger, K., Buschmans, E., Stauder, G., Gebauer, F.: The adhesion protein CD44 is modulated by proteolytic enzymes, 2nd Int. Congress on Biological Response Modifiers, San Diego/Ca. 1993 (presented Poster 21). Nakazawa M., Emancipator S.N., Lamn M.E.: Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. Journal of Experimental Medicine 164: 1973-1987, 1986. Impact factor: 14,384 Nefro-19 Steffen C., Menzel J.: Grundlagenuntersuchung zur Enzymtherapie bei Immunkomplexkrankheiten. Wiener klinische Wochenschrift 97 (8): 2-11, 1985. Imun-83
	Liek pre vnútorné použitie. Čítajte pozorne príbalové informácie. Inzertné stránky spoločnosti MUCOS Pharma CZ, s.r.o. - tel: (+420)-267 750 003